|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Sale of Royalty Rights | |||||
| Milestone Revenue | |||||
| Royalty Revenues | |||||
| Total revenues | |||||
| Costs and operating expenses | |||||
| Cost of revenues | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Impairment of in-process research and development intangible asset | |||||
| Total costs and operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Interest income | |||||
| Interest and investment income, net | |||||
| Sublease income | |||||
| Total other income, net | |||||
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Net loss per common share - basic | |||||
| Net loss per common share - diluted | |||||
| Weighted average shares of common stock outstanding - basic | |||||
| Weighted average shares of common stock outstanding - diluted | |||||
| Other comprehensive (loss) income | |||||
| Net unrealized (loss) gain on marketable debt securities | |||||
| Other comprehensive (loss) income | |||||
| Comprehensive loss | |||||
Loading...